Howard West

Howard West

UNVERIFIED PROFILE

Are you Howard West?   Register this Author

Register author
Howard West

Howard West

Publications by authors named "Howard West"

Are you Howard West?   Register this Author

84Publications

1225Reads

37Profile Views

Chemoimmunotherapy for stage IV non-small-cell lung cancer - Authors' reply.

Lancet Oncol 2019 Sep;20(9):e467

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30544-3DOI Listing
September 2019

Antibody Drug Conjugates for Cancer Treatment.

JAMA Oncol 2019 Sep 26. Epub 2019 Sep 26.

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.3552DOI Listing
September 2019

Online Cancer Information and Patient Groups.

Authors:
Howard Jack West

JAMA Oncol 2019 Jul 3. Epub 2019 Jul 3.

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.1576DOI Listing
July 2019

Moving Beyond Limited and Extensive Staging of Small Cell Lung Cancer.

Authors:
Howard Jack West

JAMA Oncol 2019 Mar 14;5(3):e185187. Epub 2019 Mar 14.

Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.5187DOI Listing
March 2019

Plasma vs Tissue Next-Generation Sequencing in Non-Small Cell Lung Cancer-Either, Both, or Neither?

JAMA Oncol 2019 Feb;5(2):148-149

Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.4304DOI Listing
February 2019

Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:531-542. Epub 2019 May 17.

4 City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237863DOI Listing
January 2019

Redefining the Value Proposition of Precision Oncology: Can We Integrate Genomic Testing Without Overselling It?

Authors:
Howard Jack West

JAMA Oncol 2018 10;4(10):1423-1424

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.3729DOI Listing
October 2018

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.

J Clin Oncol 2018 09 16;36(26):2693-2701. Epub 2018 May 16.

D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO; Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Dae Ho Lee, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Corey J. Langer, University of Pennsylvania, Philadelphia, PA; Alice T. Shaw, Massachusetts General Hospital, Boston; William Reichmann, Jeff Haney, Tim Clackson, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; Rudolf M. Huber, University Hospital of Munich, Munich, Germany; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Lyudmila A. Bazhenova and Kathryn A. Gold, University of California San Diego Moores Cancer Center, La Jolla; Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Irvine, CA; Howard L. West, Swedish Cancer Institute, Seattle, WA; and Scott N. Gettinger, Yale Cancer Center, New Haven, CT.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.5841
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.5841DOI Listing
September 2018

I Have Neutropenia-What Do I Need to Know?

JAMA Oncol 2018 09;4(9):1307

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.2653DOI Listing
September 2018

Complementary and Alternative Medicine in Cancer Care.

Authors:
Howard Jack West

JAMA Oncol 2018 Jan;4(1):139

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3120DOI Listing
January 2018

Febrile Neutropenia.

JAMA Oncol 2017 12;3(12):1751

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.1114DOI Listing
December 2017

Chimeric Antigen Receptor (CAR) T-Cell Therapy.

JAMA Oncol 2017 11;3(11):1595

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.2989DOI Listing
November 2017

Prioritizing molecular markers to test for in the initial workup of advanced non-small cell lung cancer: wants versus needs.

Authors:
Howard West

Ann Transl Med 2017 Sep;5(18):371

Medical Oncology, Swedish Cancer Institute, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.08.29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635256PMC
September 2017

Do the Data on Scalp Cooling for Patients With Breast Cancer Warrant Broad Adoption?

Authors:
Howard Jack West

JAMA Oncol 2017 08;3(8):1130-1131

Medical Oncology, Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0051DOI Listing
August 2017

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

J Clin Oncol 2017 Aug 5;35(22):2490-2498. Epub 2017 May 5.

Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5904DOI Listing
August 2017

Chemotherapy-Induced Hair Loss (Alopecia).

Authors:
Howard Jack West

JAMA Oncol 2017 08;3(8):1147

Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.1026DOI Listing
August 2017

Novel Precision Medicine Trial Designs: Umbrellas and Baskets.

Authors:
Howard Jack West

JAMA Oncol 2017 03;3(3):423

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.5299DOI Listing
March 2017

Highlights of Recent Studies of Metastatic Non-Small Cell Lung Cancer.

Authors:
Howard Jack West

JAMA Oncol 2017 Feb;3(2):159-160

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, Washington2Web Editor, JAMA Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3676DOI Listing
February 2017

Intimacy, Body Image, and Cancer.

JAMA Oncol 2016 Dec;2(12):1667

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.1196DOI Listing
December 2016

Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?

Authors:
Howard Jack West

J Clin Oncol 2016 Oct;34(30):3595-3596

Swedish Cancer Institute, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.8226DOI Listing
October 2016

Mucositis (or Stomatitis).

JAMA Oncol 2016 Oct;2(10):1379

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2103DOI Listing
October 2016

Jaundice (Hyperbilirubinemia) in Cancer.

JAMA Oncol 2016 Aug;2(8):1103

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.1236DOI Listing
August 2016

Lymph Nodes and Lymphadenopathy in Cancer.

JAMA Oncol 2016 Jul;2(7):971

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3509DOI Listing
July 2016

No Solid Evidence, Only Hollow Argument for Universal Tumor Sequencing: Show Me the Data.

Authors:
Howard Jack West

JAMA Oncol 2016 Jun;2(6):717-8

Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0075DOI Listing
June 2016

Bone Complications in Patients With Cancer.

JAMA Oncol 2016 May;2(5):695

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3495DOI Listing
May 2016

A new model: physician-patient collaboration in online communities and the clinical practice of oncology.

Am Soc Clin Oncol Educ Book 2012 :443-8

From the Department of Thoracic Oncology, Swedish Cancer Institute, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.443DOI Listing
April 2016

Young Patients With Lung Cancer-An Understudied Population.

Authors:
Howard Jack West

JAMA Oncol 2016 Mar;2(3):321

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4479DOI Listing
March 2016

Fertility and Cancer Treatment.

JAMA Oncol 2016 Feb;2(2):284

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4143DOI Listing
February 2016

Balancing Benefit, Risk, and Time to New Cancer Therapies.

Authors:
Howard Jack West

JAMA Oncol 2016 Jan;2(1):122

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4126DOI Listing
January 2016

Portacaths.

JAMA Oncol 2016 Jan;2(1):152

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3488DOI Listing
January 2016

The Slippery Slope of Broadening Treatment Eligibility and Weak End Points: Defending the Oligo in Oligometastatic Non-Small-Cell Lung Cancer.

Authors:
Howard Jack West

JAMA Oncol 2015 Dec;1(9):1219-20

Swedish Cancer Institute, Global Resource for Advancing Cancer Education (GRACE), Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2966DOI Listing
December 2015

Acquired resistance to targeted therapies in advanced non-small cell lung cancer: new strategies and new agents.

Am Soc Clin Oncol Educ Book 2013

From the Swedish Cancer Institute, Seattle, WA; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.e272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142045PMC
November 2015

Transarterial Chemoembolization.

JAMA Oncol 2015 Nov;1(8):1178

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3702DOI Listing
November 2015

Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1421-9

*Department of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA; †Department of Internal Medicine, University of Maryland, College Park, MD; ‡Department of Oncology, Lombardi Comprehensive Cancer Center of the Georgetown University, Washington, DC; §Department of Biostatistics, University of California, Davis, CA; ‖Division of Medical Oncology, Swedish Cancer Institute, Seattle, WA; ¶Department of Internal Medicine, Swedish Cancer Institute, Seattle, WA; #Department of Internal Medicine, Comprehensive Cancer Center, University of California, Davis, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153351
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000508DOI Listing
October 2015

JAMA Oncology Patient Page. The Evolution of a Cancer.

JAMA Oncol 2015 Sep;1(6):850

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2199DOI Listing
September 2015

Adjuvant Therapy.

JAMA Oncol 2015 Aug;1(5):698

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2095DOI Listing
August 2015

JAMA Oncology Patient Page. Neoadjuvant Therapy.

JAMA Oncol 2015 Jul;1(4):550

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1241DOI Listing
July 2015

JAMA Oncology Patient Page. Circulating Tumor Cells.

JAMA Oncol 2015 Jun;1(3):394

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0711DOI Listing
June 2015

JAMA Oncology Patient Page. Malignant Pleural Effusions.

Authors:
Howard Jack West

JAMA Oncol 2015 May;1(2):260

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0671DOI Listing
May 2015

JAMA Oncology Patient Page. Immune Checkpoint Inhibitors.

Authors:
Howard Jack West

JAMA Oncol 2015 Apr;1(1):115

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0137DOI Listing
April 2015

Individualizing adjuvant therapy for early stage non-small cell lung cancer: we see the destination, but we don't yet know the route.

Authors:
Howard West

J Thorac Dis 2015 Mar;7(3):235-7

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2015.01.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387408PMC
March 2015

Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.

J Clin Oncol 2014 Nov 13;32(32):3673-9. Epub 2014 Oct 13.

Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Natasha Rekhtman and James Huang, Memorial Sloan Kettering Cancer Center, New York, NY; William A. Biermann, Einstein Medical Center Montgomery, East Norriton, PA; Mari Mino-Kenudson, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Suresh S. Ramalingam, Winship Cancer Institute, Emory University, Atlanta, GA; Howard West, Swedish Cancer Institute, Seattle, WA; Sara Whitlock, Free to Breathe, Madison, WI; and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://www.jco.ascopubs.org/content/early/2014/10/10/JCO.201
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.3055
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.3055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321089PMC
November 2014

A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer.

J Thorac Oncol 2014 Oct;9(10):1532-9

*University of Colorado Anschutz Medical Campus, Aurora, CO; †New York University School of Medicine, New York, NY; ‡University of California San Francisco, San Francisco, CA; §Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY; ‖Tower Hematology Oncology Medical Group, Beverly Hills, CA; ¶King's College London, Guy's Hospital, London, United Kingdom; #Swedish Cancer Institute, Seattle, WA; **ImClone Systems, a Wholly-owned Subsidiary of Eli Lilly and Company, Bridgewater, NJ; and ††Cedar Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165478PMC
October 2014

Managing multifocal bronchioloalveolar carcinoma/lepidic predominant adenocarcinoma: changing rules for an evolving clinical entity.

Authors:
Howard Jack West

Clin Adv Hematol Oncol 2014 Sep;12(9):593-600

Swedish Cancer Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
September 2014

Afatinib for advanced mutated NSCLC: New hope or new Coke?

Authors:
Howard Jack West

J Community Support Oncol 2014 Apr;12(4):115-7

Swedish Cancer Institute, Seattle, WA USA Email:

View Article

Download full-text PDF

Source
April 2014

The evolving role of targeted therapy in early-stage and locally advanced non-small cell lung cancer.

Authors:
Howard West

Curr Oncol Rep 2011 Aug;13(4):280-9

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-011-0181-0DOI Listing
August 2011

Maintenance therapy in non-small-cell lung cancer.

Lancet 2009 Oct 18;374(9699):1398-400. Epub 2009 Sep 18.

Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)61598-1DOI Listing
October 2009

Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer.

Chest 2009 Oct;136(4):1112-1118

Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.08-2484DOI Listing
October 2009

Bronchioloalveolar carcinoma: not as easy as "BAC".

J Thorac Oncol 2009 Sep;4(9):1047-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181b6ebdaDOI Listing
September 2009

Molecular analysis-based treatment strategies for the management of non-small cell lung cancer.

J Thorac Oncol 2009 Sep;4(9 Suppl 2):S1029-39; quiz S1041-2

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181b27170DOI Listing
September 2009

Novel targeted agents for lung cancer.

Authors:
Howard Jack West

Clin Lung Cancer 2009 Mar;10 Suppl 1:S41-6

Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.s.007DOI Listing
March 2009

Bronchioloalveolar carcinoma: the case for two diseases.

Clin Lung Cancer 2008 Jan;9(1):24-9

Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.004DOI Listing
January 2008

Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.

J Clin Oncol 2006 Apr;24(12):1807-13

Swedish Cancer Institute/Puget Sound Oncology Consortium, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.9890DOI Listing
April 2006

Emerging approaches to advanced bronchioloalveolar carcinoma.

Authors:
Howard West

Curr Treat Options Oncol 2006 Jan;7(1):69-76

Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
January 2006

Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer.

Semin Oncol 2005 Jun;32(3):284-92

Swedish Cancer Institute, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
June 2005

Myalgias and arthralgias associated with paclitaxel.

Oncology (Williston Park) 2003 Feb;17(2):271-7; discussion 281-2, 286-8

Department of Pharmacy, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
February 2003